Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Torres

Showing results (1-10 of 1,447) with videos related to

Pageof 145
Sort By:
Kidney International|October 14, 2005
Vasopressin antagonists in polycystic kidney diseaseVicente E Torres
Annual Review of Medicine|December 11, 2014
Vasopressin receptor antagonists, heart failure, and polycystic kidney diseaseVicente E Torres
Journal of the American Society of Nephrology : JASN|June 13, 2009
Type II calcimimetics and polycystic kidney disease: unanswered questionsVicente E Torres
Investigacion Clinica|May 20, 1998
A practical device designed to concentrate cells for cytomorphological studies of biological fluidsE Torres-Guerra
Kidney International|January 23, 2026
The many faces of cholesterol in autosomal dominant polycystic kidney diseaseVicente E Torres
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|March 27, 2012
[Botulinum toxin for ocular complications after facial palsy]E Torres Suárez
Administrative Radiology : AR|May 9, 1989
The latest wave in patient therapy. Managing a gallstone treatment centerW E Torres
Contributions to Nephrology|January 1, 1995
Polycystic liver diseaseV E Torres
Kidney International|October 16, 2009
Vasopressin in chronic kidney disease: an elephant in the room?Vicente E Torres
Kidney International|January 20, 1999
Apoptosis in cystogenesis: hands on or hands off?V E Torres
Pageof 145

Showing results (1-10 of 1,447) with videos related to

Sort By:
Pageof 145
Kidney International|October 14, 2005
Vasopressin antagonists in polycystic kidney diseaseVicente E Torres
Annual Review of Medicine|December 11, 2014
Vasopressin receptor antagonists, heart failure, and polycystic kidney diseaseVicente E Torres
Journal of the American Society of Nephrology : JASN|June 13, 2009
Type II calcimimetics and polycystic kidney disease: unanswered questionsVicente E Torres
Investigacion Clinica|May 20, 1998
A practical device designed to concentrate cells for cytomorphological studies of biological fluidsE Torres-Guerra
Kidney International|January 23, 2026
The many faces of cholesterol in autosomal dominant polycystic kidney diseaseVicente E Torres
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|March 27, 2012
[Botulinum toxin for ocular complications after facial palsy]E Torres Suárez
Administrative Radiology : AR|May 9, 1989
The latest wave in patient therapy. Managing a gallstone treatment centerW E Torres
Contributions to Nephrology|January 1, 1995
Polycystic liver diseaseV E Torres
Kidney International|October 16, 2009
Vasopressin in chronic kidney disease: an elephant in the room?Vicente E Torres
Kidney International|January 20, 1999
Apoptosis in cystogenesis: hands on or hands off?V E Torres
Pageof 145